SA PRO
Free Account
Themes
BBOTBBOTNASDAQ
Loading
OverviewIntelligenceChartsNews

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
2 analysts·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
2100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 140% higher.

Bear Case
$18.00
+85%
Consensus
$23.33
+140%
Bull Case
$27.00
+177%
Price Range2 analysts
Low
Consensus
High
$18.00
$27.00
Current Target
Current Price
$9.74
Upside to Target
$13.59

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 10, 2026Stifel Nicolaus
BridgeBio Oncology initiated with a Buy at Stifel
Target:$23.00
+112.2%from $10.84
Jan 9, 2026Raymond James
BridgeBio Oncology initiated with an Outperform at Raymond James
Target:$24.00
+80.5%from $13.30
Jan 8, 2026Morgan Stanley
BridgeBio Oncology price target lowered to $18 from $20 at Morgan Stanley
Target:$18.00
+39.3%from $12.92
Dec 5, 2025Morgan Stanley
BridgeBio Oncology initiated with an Overweight at Morgan Stanley
Target:$20.00
+73.3%from $11.54
Sep 17, 2025Leerink Partners
BridgeBio Oncology initiated with an Outperform at Leerink
Target:$25.00
+131.7%from $10.79
Sep 15, 2025H.C. Wainwright
BridgeBio Oncology initiated with a Buy at H.C. Wainwright
Target:$27.00
+177.5%from $9.73
Sep 4, 2025Oppenheimer
BridgeBio Oncology initiated with an Outperform at Oppenheimer
Target:$23.00
+128.2%from $10.08
Aug 15, 2025Piper Sandler
BridgeBio Oncology initiated with an Overweight at Piper Sandler
Target:$21.00
+116.5%from $9.70

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance